Q5120 is a valid 2023 HCPCS Code that could be used to indicate Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo), 0.5 mg for reimbursement purposes.
Q5120 belongs to Medical Care Type of Service and has been in effect since Jul 01, 2020.
Inj pegfilgrastim-bmez 0.5mg
Q5120 code information
| HCPCS code: | Q5120 |
| Description: | INJECTION, PEGFILGRASTIM-BMEZ, BIOSIMILAR, (ZIEXTENZO), 0.5 MG |
| Effective Date: | Jul 01, 2020 |
| Added Date: | Jul 01, 2020 |
| Termination Date: | HCPCS Q5120 was terminated on Nov 30, -0001 |
| Pricing indicator: | 53 - STATUTE |
| Multi Pricing indicator: | A - NOT APPLICABLE AS HCPCS PRICED UNDER ONE METHODOLOGY |
| Coverage code: | C - CARRIER JUDGMENT |
| BETOS code: | O1E - OTHER DRUGS |
| Action code: | N - NO MAINTENANCE FOR THIS CODE |
| Type of Service: |
1 - MEDICAL CARE
P - LUMP SUM PURCHASE OF DME, PROSTHETICS, ORTHOTICS
|
| Anesthesia BUQ: | 0 |
Below a selection of HCPCS codes related to Q5120